Sharktank Research Foundation and Planetary Biosciences would like to announce the new batch of the dietary supplement Indrepta has been made and received by the distributor. The original batch was first released in November 2016 with types A and B. We now have Indrepta A and B back in stock. Type A has substituted the compound naringen with apigenin. Type B has increased the Amentoflavone amount from 50mg to 150mg per capsule. We are also introducing a new variation product called Indrepta C. It is designed to systemically help those with nonsense CF mutations. A full discussion on this product can be found at https://planetarybiosciences.com/indrepta-c/
Indrepta C now available
